Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$100.76

0.01 (0.01%)

07:25
04/14/18
04/14
07:25
04/14/18
07:25

Alnylam to hold a conference call

Management discusses the new results from the Phase 1 and Phase 1/2 open-label extension (OLE) studies of Givosiran on a conference call to be held on April 14 at 8 am. Webcast Link

  • 14

    Apr

  • 20

    Apr

  • 08

    May

  • 30

    May

  • 11

    Aug

ALNY Alnylam
$100.76

0.01 (0.01%)

04/03/18
JMPS
04/03/18
NO CHANGE
Target $207
JMPS
Outperform
JMP Securities says Alnylam selloff an 'extreme overreaction' to competitor data
After speaking to Alnylam (ALNY) management about competitor Pfizer's (PFE) positive top-line trial results for tafamidis in patients with transthyretin cardiomyopathy, JMP Securities analyst Michael King said Alnylam believes patisiran has a superior competitive profile compared to tafamidis in patients with hATTR-FAP. He views the selloff in Alnylam shares as "an extreme overreaction" to the presence of a competitor, reminding investors of recent International Symposium on Amyloidosis data that he said suggest that ALN-TTRsc02 will be well positioned with respect to tafamidis. King reiterates his Outperform rating and $207 price target on Alnylam.
04/02/18
JEFF
04/02/18
NO CHANGE
JEFF
Buy
Alnylam weakness on Pfizer data a buying opportunity, says Jefferies
Jefferies analyst Maury Raycroft noted that Alnylam (ALNY) fell by over 8% on Thursday after Pfizer (PFE) announced that the phase 3 ATTR-ACT trial assessing tafamidis in TTR-CM met its primary endpoint and that Alnylam shares are trailing the iShares Nasdaq Biotechnology Index (IBB) again today. While he thinks the tafamidis data provide important clinical outcome results that support the need for treatment and benefit in TTR-CM, he also continues to believe the benefits of knocking down/depleting TTR in earlier-stage patients, as Alnylam's patisiran is meant to do, will lead to better objective improvements, Raycroft tells investors. The analyst, who recommends investors buy Alnylam amid the weakness, keeps a Buy rating on the stock.
03/29/18
PIPR
03/29/18
NO CHANGE
Target $182
PIPR
Overweight
Piper says Pfizer's tafamidis poses minimal threat to Alnylam's patisiran
Piper Jaffray analyst Edward Tenthoff attributes weakness in shares of Alnylam (ALNY) to Pfizer (PFE) having reported that tafamidis achieved a significant reduction in all-cause mortality and frequency of cardiovascular-related hospitalizations vs. placebo at 30 months in a trial of ATTR cardiomyopathy patients. However, he would be a buyer of Alnylam amid the pullback, as he sees a minimal competitive threat, contending that patisiran's mechanism of mRNA knockdown is more potent than tafamidis' stabilization. The analyst, who expects patisiran to receive FDA approval broadly in ATTR amyloidosis polyneuropathy and cardiomyopathy by its PDUFA date of August 11, maintains an Overweight rating and $182 price target on Alnylam.
03/28/18
EVER
03/28/18
INITIATION
Target $143
EVER
In Line
Alnylam initiated with an In Line at Evercore ISI
Evercore ISI started Alnylam Pharmaceuticals with an In Line rating and $143 price target.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$7.97

-1.015 (-11.30%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Vipshop falls -11.6% »

Vipshop is down -11.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 10

    Sep

HUYA

HUYA

$28.05

-4.81 (-14.64%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
HUYA falls -14.4% »

HUYA is down -14.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.47

-3.49 (-25.00%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Switch falls -25.1% »

Switch is down -25.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUMC

Yum China

$36.25

2.03 (5.93%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Yum China rises 6.1% »

Yum China is up 6.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AAP

Advance Auto Parts

$153.90

9.11 (6.29%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Advance Auto Parts rises 6.6% »

Advance Auto Parts is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

TPR

Tapestry

$51.19

3.77 (7.95%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Tapestry rises 7.8% »

Tapestry is up 7.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 12

    Sep

AAP

Advance Auto Parts

$144.79

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44
Technical Analysis
Technical Take: Advance Auto Parts at new 52-week high after earnings »

In early trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FB

Facebook

$180.08

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44
Hot Stocks
Jana Partners buys Facebook and Alibaba in Q2, sells out of Northrop »

Barry Rosenstein's…

FB

Facebook

$180.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

MSFT

Microsoft

$108.24

(0.00%)

WFC

Wells Fargo

$57.64

(0.00%)

GOOGL

Alphabet Class A

$1,248.76

(0.00%)

GOOG

Alphabet

$1,235.10

(0.00%)

BLMN

Bloomin' Brands

$18.13

(0.00%)

NOC

Northrop Grumman

$292.10

(0.00%)

KDP

Keurig Dr Pepper

$23.75

(0.00%)

WRK

WestRock

$54.73

(0.00%)

CI

Cigna

$181.78

(0.00%)

EA

Electronic Arts

$131.29

(0.00%)

A

Agilent

$65.95

(0.00%)

AAPL

Apple

$208.87

(0.00%)

TIF

Tiffany

$130.88

(0.00%)

LRCX

Lam Research

$178.13

(0.00%)

HDS

HD Supply

$43.72

(0.00%)

ADSK

Autodesk

$133.41

(0.00%)

BSX

Boston Scientific

$33.30

(0.00%)

ZBH

Zimmer Biomet

$122.45

(0.00%)

JACK

Jack in the Box

$89.03

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 28

    Oct

  • 06

    Nov

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

F

Ford

$9.46

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:42
08/14/18
08/14
09:42
08/14/18
09:42
Hot Stocks
Ford-owned Autonomic announces partnership with Alibaba Cloud »

Autonomic, a wholly owned…

F

Ford

$9.46

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 23

    Aug

  • 31

    Aug

  • 10

    Sep

CMI

Cummins

$139.70

(0.00%)

, BZUN

Baozun

$52.66

(0.00%)

09:40
08/14/18
08/14
09:40
08/14/18
09:40
Options
Unusually active option classes on open August 14th »

Unusual total active…

CMI

Cummins

$139.70

(0.00%)

BZUN

Baozun

$52.66

(0.00%)

TPR

Tapestry

$47.42

(0.00%)

HD

Home Depot

$194.11

(0.00%)

SWN

Southwestern Energy

$5.34

(0.00%)

NWL

Newell Brands

$20.47

(0.00%)

XLE

Energy Select Sector SPDR

$74.30

(0.00%)

FXI

iShares China Large-Cap ETF

$42.15

(0.00%)

M

Macy's

$40.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 23

    Aug

  • 10

    Sep

  • 12

    Sep

  • 17

    Sep

09:40
08/14/18
08/14
09:40
08/14/18
09:40
General news
U.S. corporate bond update: issuance remains solid »

U.S. corporate bond…

DB

Deutsche Bank

$11.44

-0.375 (-3.17%)

09:39
08/14/18
08/14
09:39
08/14/18
09:39
Periodicals
Deutsche Bank to review contract of IB head Ritchie in Oct., Financial News says »

Deutsche Bank will review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNL

Synalloy

$23.55

(0.00%)

09:39
08/14/18
08/14
09:39
08/14/18
09:39
Hot Stocks
Breaking Hot Stocks news story on Synalloy »

Synalloy trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

SWCH

Switch

$13.96

-0.11 (-0.78%)

09:36
08/14/18
08/14
09:36
08/14/18
09:36
Recommendations
Switch analyst commentary  »

Switch price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$194.11

-2.19 (-1.12%)

09:35
08/14/18
08/14
09:35
08/14/18
09:35
Hot Stocks
Breaking Hot Stocks news story on Home Depot »

Home Depot says tariff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

F

Ford

$9.46

-0.275 (-2.82%)

09:33
08/14/18
08/14
09:33
08/14/18
09:33
Periodicals
Ford recalls nearly 4,000 cars in Russia, Reuters reports »

Ford is recalling 3,968…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 31

    Aug

CPT

Camden Property

$92.39

-0.01 (-0.01%)

09:31
08/14/18
08/14
09:31
08/14/18
09:31
Recommendations
Camden Property analyst commentary  »

Camden Property price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

09:30
08/14/18
08/14
09:30
08/14/18
09:30
General news
Stocks open higher as Turkey concerns ease »

Stock futures traded…

ABIL

Ability

$5.95

1.38 (30.20%)

09:30
08/14/18
08/14
09:30
08/14/18
09:30
Syndicate
Ability announces $3.35M registered direct offering »

Ability announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
08/14/18
08/14
09:30
08/14/18
09:30
General news
The U.S. July trade price report was weak »

The U.S. July trade price…

TPR

Tapestry

$47.42

-0.52 (-1.08%)

09:29
08/14/18
08/14
09:29
08/14/18
09:29
Hot Stocks
Tapestry expects 'modest' net decrease in Coach brand stores in FY19 »

Says will continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 12

    Sep

DHT

DHT Holdings

$4.31

-0.015 (-0.35%)

09:29
08/14/18
08/14
09:29
08/14/18
09:29
Downgrade
DHT Holdings rating change  »

DHT Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ABIL

Ability

$5.95

1.38 (30.20%)

09:28
08/14/18
08/14
09:28
08/14/18
09:28
Syndicate
Ability announces registered direct offering »

Ability Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGEN

Tecogen

$3.33

0.03 (0.91%)

09:25
08/14/18
08/14
09:25
08/14/18
09:25
Hot Stocks
Tecogen receives U.S. patent for catalyst formulation for Ultera emissions »

Tecogen has been granted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

MAR

Marriott

$120.48

0.23 (0.19%)

09:25
08/14/18
08/14
09:25
08/14/18
09:25
Upgrade
Marriott rating change  »

Marriott upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.